AMENDMENT NO. 9 TO LICENSE AGREEMENTLicense Agreement • March 28th, 2013 • Omthera Pharmaceuticals, Inc. • Pharmaceutical preparations
This AMENDMENT NO. 9 TO LICENSE AGREEMENT (the “Amendment”) is made and entered into as of 27 March, 2013, by and between Chrysalis Pharma AG, a corporation duly established under the laws of Switzerland with registered offices at Chilchgasse 8, 6072 Sachseln Switzerland, as successor to PVT Polyver Trust AG (“Licensor”), and Omthera Pharmaceuticals, Inc., a company duly established under the laws of Delaware with registered offices at 90 Washington Valley Road, Bedminster, NJ 07921 (“Licensee”). Licensor and Licensee are also referred to individually as “Party” and collectively as “Parties”.
